Colossal Biosciences announced on November 4, 2025, that it has acquired Viagen, the company responsible for more commercial ...

Colossal isn’t ‘bringing back’ lost species. But it might be working on something ‘useful.’ Colossal isn’t ‘bringing back’ lost species. But it might be working on something ‘useful.’ Colossal’s ...

Opinions expressed by Digital Journal contributors are their own. While de-extinction often conjures images of scientific ambition divorced from conservation reality, Colossal Biosciences has ...

Colossal Biosciences has just announced a world first breakthrough in avian genetics and secured $120 million in new funding to accelerate its dodo de-extinction project. To understand what this means ...

On April 30, 2026, the team at Colossal Biosciences announced the addition of the bluebuck antelope as the sixth species in its growing de-extinction portfolio. Here's what the company's ambitious ...

The project, actively in progress, is powered by world-first breakthroughs in antelope reproduction and stem cell science; supported by local South African conservation organizations to support ...

In October 2024, three dire wolf pups were born in a successful de-extinction project helmed by Colossal Biosciences, located in Dallas, Texas. The pups include two boys, Romulus and Remus, and a girl ...

A bioengineering company may have created the chicken before the egg. On Tuesday, May 19, Colossal Biosciences — which describes itself as "the world's first de-extinction company" — announced that it ...

Should we bring back extinct animals? Wrong question. Why are we bringing back extinct animals when we have animals, plants, and fungi that are going extinct now, daily? By 2050, up to half of all ...

Modern genetic research is “pushing the boundaries of what’s possible” by bringing extinct animals back to life, but could it lead to unexpected consequences?